Search research articles
Contact Us
Filters
Showing results (1-10 of 127) with videos related to
Page
of 13
Sort By:
European Journal of Pharmacology
|
August 4, 2004
In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families
Pierre Van Antwerpen, Jean Nève
Expert Opinion on Therapeutic Patents
|
June 9, 2020
A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)
Jalal Soubhye, Pierre Van Antwerpen, François Dufrasne
Current Medicinal Chemistry
|
January 19, 2018
Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents
Jalal Soubhye, Pierre van Antwerpen, Francois Dufrasne
Antioxidants & Redox Signaling
|
February 11, 2021
Selenocompounds and Sepsis: Redox Bypass Hypothesis for Early Diagnosis and Treatment: Part A-Early Acute Phase of Sepsis: An Extraordinary Redox Situation (Leukocyte/Endothelium Interaction Leading to Endothelial Damage)
Xavier Forceville, Pierre Van Antwerpen, Jean-Charles Preiser
Journal of Food Biochemistry
|
February 19, 2021
Anti-inflammatory, antioxidant effects, and bioaccessibility of Tigzirt propolis
Mokhtaria Yasmina Boufadi, Jalal Soubhye, Pierre Van Antwerpen
Antioxidants & Redox Signaling
|
March 15, 2022
Selenocompounds and Sepsis-Redox Bypass Hypothesis: Part B-Selenocompounds in the Management of Early Sepsis
Xavier Forceville, Pierre Van Antwerpen, Djillali Annane, et al.
Future Medicinal Chemistry
|
August 1, 2015
Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis
Jalal Soubhye, Ibaa Chikh Alard, Pierre van Antwerpen, et al.
Archives of Biochemistry and Biophysics
|
April 4, 2018
The other myeloperoxidase: Emerging functions
Luc Vanhamme, Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, et al.
Frontiers in Microbiology
|
April 10, 2023
Two new siderophores produced by <i>Pseudomonas</i> sp. NCIMB 10586: The anti-oomycete non-ribosomal peptide synthetase-dependent mupirochelin and the NRPS-independent triabactin
Camille Grosse, Nathalie Brandt, Pierre Van Antwerpen, et al.
Analytica Chimica Acta
|
April 30, 2016
Glycan characterization of biopharmaceuticals: Updates and perspectives
Ana Planinc, Jonathan Bones, Bieke Dejaegher, et al.
Page
of 13
Search research articles
Search
Showing results (1-10 of 127) with videos related to
Sort By:
Page
of 13
European Journal of Pharmacology
|
August 4, 2004
In vitro comparative assessment of the scavenging activity against three reactive oxygen species of non-steroidal anti-inflammatory drugs from the oxicam and sulfoanilide families
Pierre Van Antwerpen, Jean Nève
Expert Opinion on Therapeutic Patents
|
June 9, 2020
A patent review of myeloperoxidase inhibitors for treating chronic inflammatory syndromes (focus on cardiovascular diseases, 2013-2019)
Jalal Soubhye, Pierre Van Antwerpen, François Dufrasne
Current Medicinal Chemistry
|
January 19, 2018
Targeting Cytosolic Phospholipase A2α for Novel Anti-Inflammatory Agents
Jalal Soubhye, Pierre van Antwerpen, Francois Dufrasne
Antioxidants & Redox Signaling
|
February 11, 2021
Selenocompounds and Sepsis: Redox Bypass Hypothesis for Early Diagnosis and Treatment: Part A-Early Acute Phase of Sepsis: An Extraordinary Redox Situation (Leukocyte/Endothelium Interaction Leading to Endothelial Damage)
Xavier Forceville, Pierre Van Antwerpen, Jean-Charles Preiser
Journal of Food Biochemistry
|
February 19, 2021
Anti-inflammatory, antioxidant effects, and bioaccessibility of Tigzirt propolis
Mokhtaria Yasmina Boufadi, Jalal Soubhye, Pierre Van Antwerpen
Antioxidants & Redox Signaling
|
March 15, 2022
Selenocompounds and Sepsis-Redox Bypass Hypothesis: Part B-Selenocompounds in the Management of Early Sepsis
Xavier Forceville, Pierre Van Antwerpen, Djillali Annane, et al.
Future Medicinal Chemistry
|
August 1, 2015
Type 2 17-β hydroxysteroid dehydrogenase as a novel target for the treatment of osteoporosis
Jalal Soubhye, Ibaa Chikh Alard, Pierre van Antwerpen, et al.
Archives of Biochemistry and Biophysics
|
April 4, 2018
The other myeloperoxidase: Emerging functions
Luc Vanhamme, Karim Zouaoui Boudjeltia, Pierre Van Antwerpen, et al.
Frontiers in Microbiology
|
April 10, 2023
Two new siderophores produced by <i>Pseudomonas</i> sp. NCIMB 10586: The anti-oomycete non-ribosomal peptide synthetase-dependent mupirochelin and the NRPS-independent triabactin
Camille Grosse, Nathalie Brandt, Pierre Van Antwerpen, et al.
Analytica Chimica Acta
|
April 30, 2016
Glycan characterization of biopharmaceuticals: Updates and perspectives
Ana Planinc, Jonathan Bones, Bieke Dejaegher, et al.
Page
of 13